Share this article

Un DAO per le malattie: come Vibe Bio intende riorganizzare i finanziamenti per la biotecnologia

Il fondatore di Vibe Bio T era entusiasta di creare una DAO, ma decentralizzare la ricerca sui farmaci potrebbe risolvere un problema spinoso e tragico.

By David Z. Morris

Updated May 11, 2023, 6:10 p.m. Published Jul 15, 2022, 5:11 p.m.

Large pharmaceutical companies focus on fighting the most common (and therefore profitable) disorders. A new DAO wants to restructure incentives and boost research into rarer diseases. (Morsa/Getty Images)